Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Ranibizumab in Patients With Retinal Pigment Epithelial Detachments Secondary to Age-related Macular Degeneration

NCT00976222 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT00976222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00976222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Ranibizumab in Patients With Retinal Pigment Epithelial Detachments Secondary to Age-related Macular Degeneration
Lead sponsor
University Hospital Muenster
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2008
Completion date
December 31, 2015
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pigment epithelial detachment